Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
36.56
-0.54 (-1.46%)
At close: Sep 15, 2025, 4:00 PM EDT
36.15
-0.41 (-1.12%)
After-hours: Sep 15, 2025, 4:02 PM EDT
KNSA Employees
Kiniksa Pharmaceuticals International, had 315 employees as of December 31, 2024. The number of employees increased by 18 or 6.06% compared to the previous year.
Employees
315
Change (1Y)
18
Growth (1Y)
6.06%
Revenue / Employee
$1,680,419
Profits / Employee
$15,206
Market Cap
2.70B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 315 | 18 | 6.06% |
| Dec 31, 2023 | 297 | 77 | 35.00% |
| Dec 31, 2022 | 220 | 5 | 2.33% |
| Dec 31, 2021 | 215 | 47 | 27.98% |
| Dec 31, 2020 | 168 | 31 | 22.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KNSA News
- 12 days ago - Kiniksa Pharmaceuticals International, Plc (KNSA) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 18 days ago - Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 7 weeks ago - Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewsWire
- 3 months ago - Kiniksa Pharmaceuticals: Arcalyst Performs, KPL-387 Advancing Fast - Seeking Alpha
- 3 months ago - Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis - GlobeNewsWire
- 4 months ago - Kiniksa Pharmaceuticals: Making Steady Progress - Seeking Alpha